Skip to content

Bausch Health Companies BHC Non-cash interest expense

Non-cash interest expense at other companies

PBH
Prestige Consumer HealthcarePBH
Bausch + Lomb logo
Bausch + LombBLCO
HRO
HarrowHROW
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$1.86B-15.9%

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCostsAndDiscounts.

The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch Health Companies's non-cash interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch Health Companies's non-cash interest expense?
Bausch Health Companies (BHC) reported non-cash interest expense of $14M in Q1 2026.
How has Bausch Health Companies's non-cash interest expense changed year-over-year?
Bausch Health Companies's non-cash interest expense decreased by 6.7% year-over-year, from $15M to $14M.
What is the long-term trend for Bausch Health Companies's non-cash interest expense?
Over 4 years (2021 to 2025), Bausch Health Companies's non-cash interest expense has grown at a 14.3% compound annual growth rate (CAGR), from $55M to $94M.